CoChat

Mdm2 Promotes Genetic Instability and Transformation Independent of p53

Open access
Bouska, Alyssa, Lushnikova, Tamara, Plaza, Silvia, Eischen, Christine M. · 2008 · Molecular and Cellular Biology

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index; 16 of the 50 sources its claims cite were checked for support.

Abstract

Mdm2, a regulator of the tumor suppressor p53, is frequently overexpressed in human malignancies. Mdm2 also has unresolved, p53-independent functions that contribute to tumorigenesis. Here, we show that increased Mdm2 expression induced chromosome/chromatid breaks and delayed DNA double-strand break repair in cells lacking p53 but not in cells with a mutant form of Nbs1, a component of the Mre11/Rad50/Nbs1 DNA repair complex. A 31-amino-acid region of Mdm2 was necessary for binding to Nbs1. Mutation of conserved amino acids in the Nbs1 binding domain of Mdm2 inhibited Mdm2-Nbs1 association and prevented Mdm2 from delaying phosphorylation of H2AX and ATM-S/TQ sites, repair of DNA breaks, and resolution of DNA damage foci. Similarly, the mutation of eight amino acids in the Mdm2 binding domain of Nbs1 inhibited Mdm2-Nbs1 interaction and blocked the ability of Mdm2 to delay DNA break repair. Both Nbs1 and ATM, but not the ubiquitin ligase activity of Mdm2, were necessary to inhibit DNA break repair. Only Mdm2 with an intact Nbs1 binding domain was able to increase the frequency of chromosome/chromatid breaks and the transformation efficiency of cells lacking p53. Therefore, the interaction of Mdm2 with Nbs1 inhibited DNA break repair, leading to chromosome instability and subsequent transformation that was independent of p53.

Overview

CoChat Summary

TL;DR

Mdm2 overexpression delays DNA double-strand break repair through an interaction with Nbs1, increasing chromosome/chromatid breaks and transformation independently of p53. This p53-independent oncogenic function requires an intact Mdm2-Nbs1 binding interface and ATM, but not Mdm2’s ubiquitin ligase activity.

Key findings

  • Mdm2 overexpression increased chromosome/chromatid breaks independent of ARF and p53: in NIH 3T3 cells, vector control had 36/1,400 metaphases with breaks (2.6%) versus 75/1,275 (5.9%) with Mdm2 (P = 0.00004); in p53−/− MEFs, vector had 38/1,508 (2.5%) versus 84/1,529 (5.5%) with Mdm2 (P = 0.00006).
  • Mdm2 required Nbs1 for this effect: Mdm2 overexpression did not increase DNA breaks in Nbs1ΔB/ΔB MEFs, and Mdm2 mutants with seven or nine point mutations in its Nbs1 binding domain failed to delay DNA break repair or increase breaks.
  • The Mdm2-Nbs1 interaction mapped to a 31-amino-acid region of Mdm2 (aa 198–228) and aa 474–512 of Nbs1; eight point mutations in Nbs1’s Mdm2 binding domain severely reduced Mdm2 association and blocked Mdm2-mediated repair delay.
  • Mdm2 delayed early DNA damage signaling and repair, reducing γ-H2AX and phospho-ATM-S/TQ foci shortly after irradiation and prolonging DNA damage foci; this required Nbs1 and ATM but not Mdm2’s E3 ubiquitin ligase activity, and only Mdm2 with an intact Nbs1 binding domain increased transformation efficiency of p53−/− MEFs in soft agar.

Methods

  • Used 293T, NIH 3T3, p53−/−, ARF−/−, wild-type, ATM−/− ARF−/−, and SV40-transformed Nbs1+/+ or Nbs1ΔB/ΔB MEFs; retroviral MSCV-IRES-GFP/YFP vectors expressed wild-type or mutant Mdm2 and Nbs1 constructs.
  • Measured protein interactions by immunoprecipitation/Western blot; genomic instability by blind metaphase chromosome break analysis; DNA double-strand breaks by neutral comet assay after 5 Gy gamma irradiation; damage foci by immunofluorescence for γ-H2AX, phospho-ATM, and Nbs1; checkpoints by radioresistant DNA synthesis and G2/M assays; transformation by soft agar colony formation in p53−/− MEFs.
  • Metaphase break comparisons used Fisher’s exact test; comet tail moment was calculated by CometScore; foci were quantified for at least 50 cells per sample per interval per experiment, with experiments performed a minimum of three times.

Limitations

  • Stated: the assays used to measure S and G2/M checkpoints may not be sensitive enough to detect small differences; exactly how Mdm2 inhibits the early DNA damage response through Nbs1 remains future work, and other explanations are possible.
  • Stated: mutation of the Nbs1 binding domain did not completely abolish Mdm2-Nbs1 association, so Mdm2 with nine point mutations still produced slightly more colonies than vector control.
  • Evident from the text: most mechanistic conclusions rely on overexpression in cultured MEFs/3T3 cells, and transformation was tested only in p53−/− MEFs, with no in vivo tumor data reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/mcb.01584-07

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

15 Valid · 0 Not valid · 16 Not checked · 109 Own results and interpretations

99 more claims · 2 with their cited sources checked

Create a free account to see all 140 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 17
  • It may state two separate claims as one. 25

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

21 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 57 references

Research works printed but not linked: 3

  1. Cordon-Cardo C., 1994, Cancer Res., 54, 794
  2. Ganguli G., 2003, Mol. Cancer Res., 1, 1027
  3. Lu M. L., 2002, Clin. Cancer Res., 8, 171

Cited by

See all 105

Metadata

Authors
Bouska, A., Lushnikova, T., Plaza, S., & Eischen, C. M.
Affiliations
  • University of Nebraska Medical Center (US)
  • Vanderbilt University (US)
Venue
Molecular and Cellular Biology
Published
2008-08-01
Volume
28
Issue
15
Pages
4862-4874
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2139466852
Cited by
105
References
55
Citations by year
2026: 2 · 2025: 3 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 12 · 2017: 6 · 2016: 8 · 2015: 7 · 2014: 16 · 2013: 5 · 2012: 11
FWCI
2.33
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA117935, CA098139, CA117935, R01CA098139)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
MDM2, NBS1, p53-independent function, DNA double-strand break repair, chromosomal instability, transformation, Mre11-Rad50-Nbs1 complex, ATM, H2AX phosphorylation, DNA damage foci, chromosomal breaks
MeSH terms
Amino Acid Sequence, Animals, Cell Transformation, Neoplastic, DNA Repair, DNA-Binding Proteins, Humans, Molecular Sequence Data, Mutation, Nuclear Proteins, Protein Binding, Structure-Activity Relationship, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Cell Cycle Proteins, Tumor Suppressor Proteins, NIH 3T3 Cells, Genomic Instability, Mice, Proto-Oncogene Proteins c-mdm2, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mdm2 Promotes Genetic Instability and Transformation Independent of p53. https://app.cochat.ai/papers/10.1128/mcb.01584-07
The paper
Bouska, A., Lushnikova, T., Plaza, S., & Eischen, C. M. (2008). Mdm2 Promotes Genetic Instability and Transformation Independent of p53. Molecular and Cellular Biology. https://doi.org/10.1128/mcb.01584-07

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.